Company Profile
Hebei Changshan Biochemical Pharmaceutical provides the research, development, production, marketing, and sale of drugs for cardiovascular, cerebrovascular, diabetes, and cancer in China and globally.
It offers heparin sodium, calcium, and lithium, as well as heparinoid, LMW heparins, and sodium hyaluronate. Its portfolio also includes dalteparin sodium, enoxaparin sodium, nadroparin calcium, and heparin sodium injections, as well as sildenafil citrate tablet, and albenatide.
The company is also involved in technology development. Its portfolio also includes consulting, transfer services, investment and management of medical service projects, wholesale and retail of pharmaceuticals, and diagnosis services.
It exports its products to the United States, Germany, France, Italy, Spain, South Korea, Japan, Russia, India, the Philippines, and countries. Founded in 1992, the company is based in Shijiazhuang, China.